Discover
CARA
Cara Therapeutics, Inc.
5.32
undefined x undefined
undefined x undefined
bid
ask
-
0.14
2.56%
04:00 PM
| Ytd | -71.02% | |
| 1y | -79.19% |
5.28
day range
5.52
52 week range
| Open | 5.39 | Prev Close | 5.46 | Low | 5.28 | High | 5.52 | Mkt Cap | N/A |
| Vol | 236.85K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -0.59 |
| Beta | 0.68 | Short Ratio | 2.20 | Inst. Own | 28.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 1.01 |
| Income Statement | |||
| Total Revenue | 1.46M | ||
| Revenues (USD) | 1.46M | ||
| Gross Profit | 1.46M | ||
| Operating Expenses | 7.33M | ||
| Research and Development Expense | 171.00K | ||
| Selling, General and Administrative Expense | 6.83M | ||
| Operating Income | -5.88M | ||
| Interest Expense | 2.62M | ||
| Income Tax Expense | -398.00K | ||
| Net Income | -7.68M | ||
| Net Income Common Stock | -7.68M | ||
| Net Income Common Stock (USD) | -7.68M | ||
| Consolidated Income | -7.68M | ||
| Earnings per Basic Share | -1.73 | ||
| Earnings per Basic Share (USD) | -1.73 | ||
| Earnings per Diluted Share | -1.73 | ||
| Earning Before Interest & Taxes (EBIT) | -5.46M | ||
| Earning Before Interest & Taxes (USD) | -5.46M | ||
| Weighted Average Shares | 4.57M | ||
| Weighted Average Shares Diluted | 4.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 37.90M | ||
| Cash and Equivalents (USD) | 37.90M | ||
| Trade and Non-Trade Receivables | 4.50M | ||
| Current Assets | 43.83M | ||
| Total Assets | 43.83M | ||
| Total Debt | 44.45M | ||
| Current Liabilities | 3.97M | ||
| Debt Non-Current | 44.45M | ||
| Total Liabilities | 48.42M | ||
| Accumulated Retained Earnings (Deficit) | -755.61M | ||
| Shareholders Equity | -4.59M | ||
| Shareholders Equity (USD) | -4.59M | ||
| Total Debt (USD) | 44.45M | ||
| Inventory | 900.00K | ||
| Liabilities Non-Current | 44.45M | ||
| Trade and Non-Trade Payables | 3.97M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -1.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -658.00K | ||
| Issuance (Repayment) of Debt Securities | -1.61M | ||
| Net Cash Flow from Investing | 5.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.00M | ||
| Net Cash Flow from Operations | -4.04M | ||
| Share Based Compensation | 2.35M | ||